# US 2025/0347665 A1 · Methods for detecting particles using centrifugal field flow fractionation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0347665 A1
- Document ID: US20250347665A1
- Status: Published application
- Kind: A1
- Application number: 19/205,957
- Filed: 2025-05-12
- Published: 2025-11-13
- Earliest claimed: 2024-05-13
- Assignees: National Institute of Health Sciences; Shimadzu Corporation
- Applicants: National Institute of Health Sciences; Shimadzu Corporation
- Inventors: Eiichi YAMAMOTO; Masataka NIKKO; Kengo AOKI
- Web page: https://patentgrep.com/patent/US20250347665A1

## CPC

- G01N 15/04: Investigating sedimentation of particle suspensions
- G01N 30/32: of pressure or speed (G01N30/36 takes precedence)
- G01N 15/02: Investigating particle size or size distribution (by measuring osmotic pressure G01N7/10; investigating sedimentation of particle suspensions G01N15/04; investigating individual particles G01N15/10)
- G01N 15/10: Investigating individual particles
- G01N 30/30: of temperature
- G01N 33/03: Edible oils or edible fats
- G01N 2015/0038: {Investigating nanoparticles}
- G01N 2015/045: {by optical analysis}
- G01N 2015/1028: {Sorting particles}
- G01N 2015/1029: {Particle size}
- G01N 2030/027: {Liquid chromatography}
- G01N 2030/324: {speed, flow rate}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure provides a method of detecting size, density, or size and density of the lipid nanoparticles. The detection may be performed by centrifugal field flow fractionation using a carrier solution comprising a monosaccharide.

## Claims

### Claim 1

A method of detecting lipid nanoparticles, comprising:
detecting size, density, or size and density of the lipid nanoparticles by centrifugal field flow fractionation using a carrier solution comprising a monosaccharide.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles comprise a messenger RNA molecule.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles comprise a messenger RNA molecule encoding a vaccine.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles comprise at least one selected from the group consisting of phospholipids, triacylglycerols, cholesterol, cholesterol esters, fatty-acyl esters.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles have an average lipid concentration from 60% to 90% based on the lipid nanoparticles.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles have an average density from 0.5 g/mL to 1.5 g/mL.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles have an average diameter from 10 nm to 200 nm.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles comprise agglutinated lipid nanoparticles.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the lipid nanoparticles comprise agglutinated lipid nanoparticles having an average diameter from 50 nm to 50,000 nm.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the carrier solution comprises a phosphate buffer.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the carrier solution has a phosphate concentration from 1 mmol/L to 100 mmol/L.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the carrier solution is alkaline.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the carrier solution has a monosaccharide concentration from 1 wt % to 30 wt %.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the carrier solution has a pH from 7.0 to 9.5.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the carrier solution has a pH from 7.5 to 9.0.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the carrier solution is run in the centrifugal field flow fractionation at a flow rate from 0.5 mL/min to 1.8 mL/min.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the carrier solution is run in a temperature from 20° C. to 70° C.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the monosaccharide comprises glucose.

### Claim 19 (depends on 1)

The method according to claim 1, wherein the centrifugal field flow fractionation comprises a high-performance liquid chromatography.

### Claim 20 (depends on 1)

The method according to claim 1, wherein the detecting is performed using at least one selected from the group consisting of a multi-angle light scattering (MALS) detector, a photodiode array detector, and an absorbance detector.
